nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabigatran etexilate—ABCB1—ulcerative colitis	0.493	1	CbGaD
Dabigatran etexilate—F2—portal vein—ulcerative colitis	0.0441	0.436	CbGeAlD
Dabigatran etexilate—ABCB1—Methylprednisolone—ulcerative colitis	0.0249	0.257	CbGbCtD
Dabigatran etexilate—ABCB1—Betamethasone—ulcerative colitis	0.0162	0.167	CbGbCtD
Dabigatran etexilate—ABCB1—Prednisolone—ulcerative colitis	0.016	0.165	CbGbCtD
Dabigatran etexilate—ABCB1—Hydrocortisone—ulcerative colitis	0.0152	0.157	CbGbCtD
Dabigatran etexilate—ABCB1—Prednisone—ulcerative colitis	0.0151	0.156	CbGbCtD
Dabigatran etexilate—ABCB1—Dexamethasone—ulcerative colitis	0.00943	0.0974	CbGbCtD
Dabigatran etexilate—F2—Common Pathway—PROCR—ulcerative colitis	0.0069	0.0893	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—digestive system—ulcerative colitis	0.00545	0.0538	CbGeAlD
Dabigatran etexilate—CES2—NRF2 pathway—SLC39A11—ulcerative colitis	0.0047	0.0608	CbGpPWpGaD
Dabigatran etexilate—CES2—smooth muscle tissue—ulcerative colitis	0.00421	0.0416	CbGeAlD
Dabigatran etexilate—UGT1A9—digestive system—ulcerative colitis	0.00413	0.0408	CbGeAlD
Dabigatran etexilate—UGT2B15—liver—ulcerative colitis	0.00406	0.0401	CbGeAlD
Dabigatran etexilate—F2—Formation of Fibrin Clot (Clotting Cascade)—PROCR—ulcerative colitis	0.00396	0.0513	CbGpPWpGaD
Dabigatran etexilate—F2—epithelium—ulcerative colitis	0.00392	0.0388	CbGeAlD
Dabigatran etexilate—UGT2B7—digestive system—ulcerative colitis	0.00333	0.0329	CbGeAlD
Dabigatran etexilate—CES2—digestive system—ulcerative colitis	0.00333	0.0329	CbGeAlD
Dabigatran etexilate—UGT1A9—liver—ulcerative colitis	0.00307	0.0304	CbGeAlD
Dabigatran etexilate—F2—lymphoid tissue—ulcerative colitis	0.00302	0.0298	CbGeAlD
Dabigatran etexilate—F2—digestive system—ulcerative colitis	0.00298	0.0295	CbGeAlD
Dabigatran etexilate—CES1—lymphoid tissue—ulcerative colitis	0.00277	0.0274	CbGeAlD
Dabigatran etexilate—CES1—NRF2 pathway—SLC39A11—ulcerative colitis	0.00277	0.0358	CbGpPWpGaD
Dabigatran etexilate—CES1—digestive system—ulcerative colitis	0.00274	0.0271	CbGeAlD
Dabigatran etexilate—UGT2B7—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.0026	0.0336	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—liver—ulcerative colitis	0.00248	0.0245	CbGeAlD
Dabigatran etexilate—CES2—liver—ulcerative colitis	0.00248	0.0245	CbGeAlD
Dabigatran etexilate—F2—liver—ulcerative colitis	0.00222	0.022	CbGeAlD
Dabigatran etexilate—NQO2—liver—ulcerative colitis	0.00221	0.0219	CbGeAlD
Dabigatran etexilate—CES1—liver—ulcerative colitis	0.00204	0.0202	CbGeAlD
Dabigatran etexilate—F2—Complement and Coagulation Cascades—MASP2—ulcerative colitis	0.00193	0.025	CbGpPWpGaD
Dabigatran etexilate—F2—Cell surface interactions at the vascular wall—PROCR—ulcerative colitis	0.00176	0.0228	CbGpPWpGaD
Dabigatran etexilate—F2—Thrombin signalling through proteinase activated receptors (PARs)—GNA12—ulcerative colitis	0.0017	0.022	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—NRF2 pathway—SLC39A11—ulcerative colitis	0.00159	0.0206	CbGpPWpGaD
Dabigatran etexilate—F2—PAR1-mediated thrombin signaling events—GNA12—ulcerative colitis	0.00134	0.0174	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—NRF2 pathway—SLC39A11—ulcerative colitis	0.00129	0.0167	CbGpPWpGaD
Dabigatran etexilate—F2—FOXA2 and FOXA3 transcription factor networks—HNF4A—ulcerative colitis	0.00114	0.0148	CbGpPWpGaD
Dabigatran etexilate—F2—Regulation of IGF Activity by IGFBP—MMP1—ulcerative colitis	0.00106	0.0138	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—MPO—ulcerative colitis	0.000983	0.0127	CbGpPWpGaD
Dabigatran etexilate—F2—IL1 and megakaryotyces in obesity—ICAM1—ulcerative colitis	0.000869	0.0112	CbGpPWpGaD
Dabigatran etexilate—ABCB1—epithelium—ulcerative colitis	0.000843	0.00833	CbGeAlD
Dabigatran etexilate—ABCB1—Allograft Rejection—MICA—ulcerative colitis	0.000824	0.0107	CbGpPWpGaD
Dabigatran etexilate—CES2—Fluoropyrimidine Activity—TP53—ulcerative colitis	0.000805	0.0104	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—MPO—ulcerative colitis	0.0008	0.0104	CbGpPWpGaD
Dabigatran etexilate—F2—Post-translational protein modification—MUC3A—ulcerative colitis	0.000725	0.00938	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Biological oxidations—PTGS1—ulcerative colitis	0.000701	0.00906	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000697	0.00902	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	0.000692	0.00896	CbGpPWpGaD
Dabigatran etexilate—F2—Cell surface interactions at the vascular wall—ITGAL—ulcerative colitis	0.000676	0.00875	CbGpPWpGaD
Dabigatran etexilate—F2—IL1 and megakaryotyces in obesity—IFNG—ulcerative colitis	0.000661	0.00855	CbGpPWpGaD
Dabigatran etexilate—ABCB1—lymphoid tissue—ulcerative colitis	0.00065	0.00642	CbGeAlD
Dabigatran etexilate—ABCB1—digestive system—ulcerative colitis	0.000642	0.00634	CbGeAlD
Dabigatran etexilate—F2—Selenium Micronutrient Network—MPO—ulcerative colitis	0.000635	0.00822	CbGpPWpGaD
Dabigatran etexilate—F2—IL1 and megakaryotyces in obesity—IL1B—ulcerative colitis	0.00059	0.00763	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—PTGS1—ulcerative colitis	0.000585	0.00757	CbGpPWpGaD
Dabigatran etexilate—F2—IL1 and megakaryotyces in obesity—MMP9—ulcerative colitis	0.000556	0.00719	CbGpPWpGaD
Dabigatran etexilate—F2—IL1 and megakaryotyces in obesity—NFKB1—ulcerative colitis	0.00055	0.00712	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000529	0.00685	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—CRP—ulcerative colitis	0.000517	0.00669	CbGpPWpGaD
Dabigatran etexilate—F2—Regulation of Actin Cytoskeleton—GNA12—ulcerative colitis	0.000497	0.00643	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—CXCR1—ulcerative colitis	0.000495	0.00641	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—PROCR—ulcerative colitis	0.000478	0.00619	CbGpPWpGaD
Dabigatran etexilate—ABCB1—liver—ulcerative colitis	0.000478	0.00472	CbGeAlD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—ICAM1—ulcerative colitis	0.000475	0.00615	CbGpPWpGaD
Dabigatran etexilate—CES1—Fluoropyrimidine Activity—TP53—ulcerative colitis	0.000475	0.00614	CbGpPWpGaD
Dabigatran etexilate—F2—FOXA2 and FOXA3 transcription factor networks—ALB—ulcerative colitis	0.000446	0.00577	CbGpPWpGaD
Dabigatran etexilate—F2—Syndecan-4-mediated signaling events—MMP9—ulcerative colitis	0.000442	0.00571	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—CCL20—ulcerative colitis	0.000435	0.00563	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—CRP—ulcerative colitis	0.000421	0.00544	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—ALB—ulcerative colitis	0.000396	0.00513	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—CXCR2—ulcerative colitis	0.000388	0.00501	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—ICAM1—ulcerative colitis	0.000387	0.005	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—CCR6—ulcerative colitis	0.000364	0.00471	CbGpPWpGaD
Dabigatran etexilate—F2—Angiopoietin receptor Tie2-mediated signaling—RELA—ulcerative colitis	0.000363	0.00469	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—GNA12—ulcerative colitis	0.000362	0.00469	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—IFNG—ulcerative colitis	0.000362	0.00468	CbGpPWpGaD
Dabigatran etexilate—Nervous system disorder—Mesalazine—ulcerative colitis	0.000359	0.00155	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Mesalazine—ulcerative colitis	0.000359	0.00154	CcSEcCtD
Dabigatran etexilate—Urticaria—Budesonide—ulcerative colitis	0.000358	0.00154	CcSEcCtD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—RELA—ulcerative colitis	0.000357	0.00462	CbGpPWpGaD
Dabigatran etexilate—Abdominal pain—Budesonide—ulcerative colitis	0.000356	0.00153	CcSEcCtD
Dabigatran etexilate—Skin disorder—Mesalazine—ulcerative colitis	0.000356	0.00153	CcSEcCtD
Dabigatran etexilate—F2—Post-translational protein modification—MUC2—ulcerative colitis	0.000354	0.00458	CbGpPWpGaD
Dabigatran etexilate—Alanine aminotransferase increased—Prednisone—ulcerative colitis	0.000348	0.0015	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000347	0.00149	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Triamcinolone—ulcerative colitis	0.000347	0.00149	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Methylprednisolone—ulcerative colitis	0.000346	0.00149	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Triamcinolone—ulcerative colitis	0.000345	0.00149	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Methylprednisolone—ulcerative colitis	0.000344	0.00148	CcSEcCtD
Dabigatran etexilate—F2—Metabolism of proteins—MUC3A—ulcerative colitis	0.000344	0.00445	CbGpPWpGaD
Dabigatran etexilate—Acute coronary syndrome—Betamethasone—ulcerative colitis	0.000344	0.00148	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Dexamethasone—ulcerative colitis	0.000344	0.00148	CcSEcCtD
Dabigatran etexilate—Hypotension—Mesalazine—ulcerative colitis	0.000342	0.00147	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Betamethasone—ulcerative colitis	0.000342	0.00147	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Dexamethasone—ulcerative colitis	0.000342	0.00147	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Methylprednisolone—ulcerative colitis	0.000338	0.00146	CcSEcCtD
Dabigatran etexilate—F2—Selenium Micronutrient Network—CRP—ulcerative colitis	0.000334	0.00432	CbGpPWpGaD
Dabigatran etexilate—Musculoskeletal discomfort—Mesalazine—ulcerative colitis	0.000334	0.00144	CcSEcCtD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.000332	0.0043	CbGpPWpGaD
Dabigatran etexilate—Hypersensitivity—Budesonide—ulcerative colitis	0.000332	0.00143	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Hydrocortisone—ulcerative colitis	0.000331	0.00143	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Azathioprine—ulcerative colitis	0.000329	0.00142	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Mesalazine—ulcerative colitis	0.000326	0.00141	CcSEcCtD
Dabigatran etexilate—Asthenia—Budesonide—ulcerative colitis	0.000323	0.00139	CcSEcCtD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—IL1B—ulcerative colitis	0.000323	0.00417	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—ALB—ulcerative colitis	0.000322	0.00417	CbGpPWpGaD
Dabigatran etexilate—Dyspepsia—Mesalazine—ulcerative colitis	0.000322	0.00139	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Methylprednisolone—ulcerative colitis	0.00032	0.00138	CcSEcCtD
Dabigatran etexilate—UGT2B7—Biological oxidations—PTGS1—ulcerative colitis	0.000319	0.00413	CbGpPWpGaD
Dabigatran etexilate—Malnutrition—Hydrocortisone—ulcerative colitis	0.000319	0.00137	CcSEcCtD
Dabigatran etexilate—Pruritus—Budesonide—ulcerative colitis	0.000319	0.00137	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Azathioprine—ulcerative colitis	0.000318	0.00137	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000316	0.00136	CcSEcCtD
Dabigatran etexilate—Fatigue—Mesalazine—ulcerative colitis	0.000316	0.00136	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Dexamethasone—ulcerative colitis	0.000315	0.00136	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Betamethasone—ulcerative colitis	0.000315	0.00136	CcSEcCtD
Dabigatran etexilate—Constipation—Mesalazine—ulcerative colitis	0.000313	0.00135	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Dexamethasone—ulcerative colitis	0.000313	0.00135	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Betamethasone—ulcerative colitis	0.000313	0.00135	CcSEcCtD
Dabigatran etexilate—Angiopathy—Methylprednisolone—ulcerative colitis	0.000312	0.00135	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Methylprednisolone—ulcerative colitis	0.000311	0.00134	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.00031	0.00134	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Budesonide—ulcerative colitis	0.000308	0.00133	CcSEcCtD
Dabigatran etexilate—F2—Cell surface interactions at the vascular wall—MMP1—ulcerative colitis	0.000308	0.00398	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—ICAM1—ulcerative colitis	0.000307	0.00398	CbGpPWpGaD
Dabigatran etexilate—F2—Regulation of Actin Cytoskeleton—CD14—ulcerative colitis	0.000307	0.00397	CbGpPWpGaD
Dabigatran etexilate—F2—Angiopoietin receptor Tie2-mediated signaling—NFKB1—ulcerative colitis	0.000306	0.00396	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000304	0.00393	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—NFKB1—ulcerative colitis	0.000301	0.00389	CbGpPWpGaD
Dabigatran etexilate—Malnutrition—Methylprednisolone—ulcerative colitis	0.0003	0.00129	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Prednisone—ulcerative colitis	0.000299	0.00129	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.000299	0.00129	CcSEcCtD
Dabigatran etexilate—Angioedema—Prednisolone—ulcerative colitis	0.000298	0.00129	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Prednisone—ulcerative colitis	0.000298	0.00128	CcSEcCtD
Dabigatran etexilate—Dizziness—Budesonide—ulcerative colitis	0.000298	0.00128	CcSEcCtD
Dabigatran etexilate—CES2—NRF2 pathway—TGFB1—ulcerative colitis	0.000298	0.00385	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	0.000298	0.00385	CbGpPWpGaD
Dabigatran etexilate—F2—G alpha (q) signalling events—GHRL—ulcerative colitis	0.000297	0.00385	CbGpPWpGaD
Dabigatran etexilate—Hypersensitivity—Azathioprine—ulcerative colitis	0.000296	0.00128	CcSEcCtD
Dabigatran etexilate—F2—Folate Metabolism—IFNG—ulcerative colitis	0.000294	0.00381	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—GHRL—ulcerative colitis	0.000294	0.0038	CbGpPWpGaD
Dabigatran etexilate—Syncope—Prednisolone—ulcerative colitis	0.000293	0.00126	CcSEcCtD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.000292	0.00377	CbGpPWpGaD
Dabigatran etexilate—Angioedema—Hydrocortisone—ulcerative colitis	0.000292	0.00126	CcSEcCtD
Dabigatran etexilate—Urticaria—Mesalazine—ulcerative colitis	0.000291	0.00125	CcSEcCtD
Dabigatran etexilate—Back pain—Triamcinolone—ulcerative colitis	0.000291	0.00125	CcSEcCtD
Dabigatran etexilate—F2—Folate Metabolism—RELA—ulcerative colitis	0.00029	0.00376	CbGpPWpGaD
Dabigatran etexilate—Abdominal pain—Mesalazine—ulcerative colitis	0.000289	0.00125	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Prednisolone—ulcerative colitis	0.000287	0.00124	CcSEcCtD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—HNF4A—ulcerative colitis	0.000287	0.00372	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—CHP1—ulcerative colitis	0.000287	0.00371	CbGpPWpGaD
Dabigatran etexilate—Vomiting—Budesonide—ulcerative colitis	0.000286	0.00123	CcSEcCtD
Dabigatran etexilate—Syncope—Hydrocortisone—ulcerative colitis	0.000286	0.00123	CcSEcCtD
Dabigatran etexilate—Angiopathy—Betamethasone—ulcerative colitis	0.000284	0.00122	CcSEcCtD
Dabigatran etexilate—Angiopathy—Dexamethasone—ulcerative colitis	0.000284	0.00122	CcSEcCtD
Dabigatran etexilate—Rash—Budesonide—ulcerative colitis	0.000284	0.00122	CcSEcCtD
Dabigatran etexilate—Dermatitis—Budesonide—ulcerative colitis	0.000284	0.00122	CcSEcCtD
Dabigatran etexilate—Headache—Budesonide—ulcerative colitis	0.000282	0.00121	CcSEcCtD
Dabigatran etexilate—Hypertension—Prednisolone—ulcerative colitis	0.000282	0.00121	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Hydrocortisone—ulcerative colitis	0.00028	0.00121	CcSEcCtD
Dabigatran etexilate—Hypertension—Hydrocortisone—ulcerative colitis	0.000275	0.00119	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Azathioprine—ulcerative colitis	0.000275	0.00118	CcSEcCtD
Dabigatran etexilate—Angioedema—Triamcinolone—ulcerative colitis	0.000275	0.00118	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Prednisone—ulcerative colitis	0.000274	0.00118	CcSEcCtD
Dabigatran etexilate—Angioedema—Methylprednisolone—ulcerative colitis	0.000274	0.00118	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Prednisone—ulcerative colitis	0.000273	0.00117	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Mesalazine—ulcerative colitis	0.00027	0.00116	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.00027	0.00116	CcSEcCtD
Dabigatran etexilate—Syncope—Triamcinolone—ulcerative colitis	0.000269	0.00116	CcSEcCtD
Dabigatran etexilate—Syncope—Methylprednisolone—ulcerative colitis	0.000269	0.00116	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Prednisone—ulcerative colitis	0.000268	0.00115	CcSEcCtD
Dabigatran etexilate—Nausea—Budesonide—ulcerative colitis	0.000267	0.00115	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Prednisolone—ulcerative colitis	0.000267	0.00115	CcSEcCtD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.000266	0.00344	CbGpPWpGaD
Dabigatran etexilate—Dizziness—Azathioprine—ulcerative colitis	0.000266	0.00114	CcSEcCtD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	0.000265	0.00344	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	0.000264	0.00342	CbGpPWpGaD
Dabigatran etexilate—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000264	0.00114	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.000263	0.00113	CcSEcCtD
Dabigatran etexilate—Asthenia—Mesalazine—ulcerative colitis	0.000263	0.00113	CcSEcCtD
Dabigatran etexilate—F2—Folate Metabolism—IL1B—ulcerative colitis	0.000262	0.0034	CbGpPWpGaD
Dabigatran etexilate—Shock—Prednisolone—ulcerative colitis	0.000262	0.00113	CcSEcCtD
Dabigatran etexilate—Cough—Triamcinolone—ulcerative colitis	0.000262	0.00113	CcSEcCtD
Dabigatran etexilate—F2—Folate Metabolism—IL2—ulcerative colitis	0.000261	0.00338	CbGpPWpGaD
Dabigatran etexilate—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.00026	0.00112	CcSEcCtD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.00026	0.00336	CbGpPWpGaD
Dabigatran etexilate—Hypertension—Triamcinolone—ulcerative colitis	0.000259	0.00112	CcSEcCtD
Dabigatran etexilate—UGT1A9—Biological oxidations—PTGS1—ulcerative colitis	0.000259	0.00335	CbGpPWpGaD
Dabigatran etexilate—Pruritus—Mesalazine—ulcerative colitis	0.000259	0.00112	CcSEcCtD
Dabigatran etexilate—Hypertension—Methylprednisolone—ulcerative colitis	0.000259	0.00111	CcSEcCtD
Dabigatran etexilate—Infection—Hydrocortisone—ulcerative colitis	0.000259	0.00111	CcSEcCtD
Dabigatran etexilate—Shock—Hydrocortisone—ulcerative colitis	0.000256	0.0011	CcSEcCtD
Dabigatran etexilate—F2—Selenium Micronutrient Network—ALB—ulcerative colitis	0.000256	0.00331	CbGpPWpGaD
Dabigatran etexilate—Vomiting—Azathioprine—ulcerative colitis	0.000256	0.0011	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000255	0.0011	CcSEcCtD
Dabigatran etexilate—Arthralgia—Methylprednisolone—ulcerative colitis	0.000255	0.0011	CcSEcCtD
Dabigatran etexilate—Rash—Azathioprine—ulcerative colitis	0.000253	0.00109	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000253	0.00109	CcSEcCtD
Dabigatran etexilate—Dermatitis—Azathioprine—ulcerative colitis	0.000253	0.00109	CcSEcCtD
Dabigatran etexilate—F2—GPCR ligand binding—CXCR1—ulcerative colitis	0.000253	0.00327	CbGpPWpGaD
Dabigatran etexilate—Skin disorder—Hydrocortisone—ulcerative colitis	0.000253	0.00109	CcSEcCtD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—CALM3—ulcerative colitis	0.000252	0.00326	CbGpPWpGaD
Dabigatran etexilate—Headache—Azathioprine—ulcerative colitis	0.000252	0.00108	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Mesalazine—ulcerative colitis	0.000251	0.00108	CcSEcCtD
Dabigatran etexilate—Angioedema—Betamethasone—ulcerative colitis	0.000249	0.00107	CcSEcCtD
Dabigatran etexilate—Angioedema—Dexamethasone—ulcerative colitis	0.000249	0.00107	CcSEcCtD
Dabigatran etexilate—UGT2B15—Metabolism—DLD—ulcerative colitis	0.000248	0.00321	CbGpPWpGaD
Dabigatran etexilate—Angiopathy—Prednisone—ulcerative colitis	0.000247	0.00107	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Prednisone—ulcerative colitis	0.000246	0.00106	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000245	0.00106	CcSEcCtD
Dabigatran etexilate—F2—Folate Metabolism—NFKB1—ulcerative colitis	0.000245	0.00317	CbGpPWpGaD
Dabigatran etexilate—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000245	0.00105	CcSEcCtD
Dabigatran etexilate—Syncope—Dexamethasone—ulcerative colitis	0.000244	0.00105	CcSEcCtD
Dabigatran etexilate—Syncope—Betamethasone—ulcerative colitis	0.000244	0.00105	CcSEcCtD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000244	0.00316	CbGpPWpGaD
Dabigatran etexilate—Infection—Triamcinolone—ulcerative colitis	0.000244	0.00105	CcSEcCtD
Dabigatran etexilate—Hypotension—Hydrocortisone—ulcerative colitis	0.000243	0.00105	CcSEcCtD
Dabigatran etexilate—Infection—Methylprednisolone—ulcerative colitis	0.000243	0.00105	CcSEcCtD
Dabigatran etexilate—Dizziness—Mesalazine—ulcerative colitis	0.000242	0.00104	CcSEcCtD
Dabigatran etexilate—Shock—Triamcinolone—ulcerative colitis	0.000241	0.00104	CcSEcCtD
Dabigatran etexilate—Shock—Methylprednisolone—ulcerative colitis	0.000241	0.00104	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.00024	0.00103	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Dexamethasone—ulcerative colitis	0.00024	0.00103	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Betamethasone—ulcerative colitis	0.00024	0.00103	CcSEcCtD
Dabigatran etexilate—Nausea—Azathioprine—ulcerative colitis	0.000239	0.00103	CcSEcCtD
Dabigatran etexilate—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—ulcerative colitis	0.000238	0.00308	CbGpPWpGaD
Dabigatran etexilate—Skin disorder—Methylprednisolone—ulcerative colitis	0.000238	0.00102	CcSEcCtD
Dabigatran etexilate—Malnutrition—Prednisone—ulcerative colitis	0.000237	0.00102	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000237	0.00102	CcSEcCtD
Dabigatran etexilate—Hypertension—Betamethasone—ulcerative colitis	0.000235	0.00101	CcSEcCtD
Dabigatran etexilate—Hypertension—Dexamethasone—ulcerative colitis	0.000235	0.00101	CcSEcCtD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—TNF—ulcerative colitis	0.000234	0.00303	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—IFNG—ulcerative colitis	0.000234	0.00302	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	0.000234	0.00302	CbGpPWpGaD
Dabigatran etexilate—Vomiting—Mesalazine—ulcerative colitis	0.000233	0.001	CcSEcCtD
Dabigatran etexilate—Rash—Mesalazine—ulcerative colitis	0.000231	0.000994	CcSEcCtD
Dabigatran etexilate—Dermatitis—Mesalazine—ulcerative colitis	0.000231	0.000993	CcSEcCtD
Dabigatran etexilate—F2—Selenium Micronutrient Network—RELA—ulcerative colitis	0.000231	0.00298	CbGpPWpGaD
Dabigatran etexilate—Headache—Mesalazine—ulcerative colitis	0.000229	0.000988	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000229	0.000987	CcSEcCtD
Dabigatran etexilate—Hypotension—Methylprednisolone—ulcerative colitis	0.000229	0.000985	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000225	0.000968	CcSEcCtD
Dabigatran etexilate—Fatigue—Hydrocortisone—ulcerative colitis	0.000224	0.000967	CcSEcCtD
Dabigatran etexilate—F2—Selenium Micronutrient Network—PTGS2—ulcerative colitis	0.000224	0.0029	CbGpPWpGaD
Dabigatran etexilate—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000223	0.000962	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000223	0.00096	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Betamethasone—ulcerative colitis	0.000222	0.000958	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.000222	0.000958	CcSEcCtD
Dabigatran etexilate—F2—GPCR ligand binding—CCL20—ulcerative colitis	0.000222	0.00287	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL17A—ulcerative colitis	0.000222	0.00287	CbGpPWpGaD
Dabigatran etexilate—Infection—Betamethasone—ulcerative colitis	0.000221	0.000952	CcSEcCtD
Dabigatran etexilate—Infection—Dexamethasone—ulcerative colitis	0.000221	0.000952	CcSEcCtD
Dabigatran etexilate—Anaemia—Prednisone—ulcerative colitis	0.000219	0.000945	CcSEcCtD
Dabigatran etexilate—Shock—Betamethasone—ulcerative colitis	0.000219	0.000943	CcSEcCtD
Dabigatran etexilate—Shock—Dexamethasone—ulcerative colitis	0.000219	0.000943	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Triamcinolone—ulcerative colitis	0.000219	0.000941	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000218	0.00094	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Betamethasone—ulcerative colitis	0.000218	0.00094	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000218	0.000938	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000218	0.000938	CcSEcCtD
Dabigatran etexilate—Nausea—Mesalazine—ulcerative colitis	0.000218	0.000937	CcSEcCtD
Dabigatran etexilate—Angioedema—Prednisone—ulcerative colitis	0.000217	0.000934	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Triamcinolone—ulcerative colitis	0.000216	0.00093	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000215	0.000927	CcSEcCtD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.000215	0.00278	CbGpPWpGaD
Dabigatran etexilate—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000213	0.000917	CcSEcCtD
Dabigatran etexilate—Syncope—Prednisone—ulcerative colitis	0.000213	0.000917	CcSEcCtD
Dabigatran etexilate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000212	0.00274	CbGpPWpGaD
Dabigatran etexilate—Urticaria—Prednisolone—ulcerative colitis	0.000212	0.000912	CcSEcCtD
Dabigatran etexilate—Fatigue—Triamcinolone—ulcerative colitis	0.000211	0.00091	CcSEcCtD
Dabigatran etexilate—Fatigue—Methylprednisolone—ulcerative colitis	0.000211	0.000908	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Prednisone—ulcerative colitis	0.000209	0.000899	CcSEcCtD
Dabigatran etexilate—F2—Selenium Micronutrient Network—IL1B—ulcerative colitis	0.000208	0.0027	CbGpPWpGaD
Dabigatran etexilate—Hypotension—Dexamethasone—ulcerative colitis	0.000208	0.000895	CcSEcCtD
Dabigatran etexilate—Hypotension—Betamethasone—ulcerative colitis	0.000208	0.000895	CcSEcCtD
Dabigatran etexilate—Urticaria—Hydrocortisone—ulcerative colitis	0.000207	0.000891	CcSEcCtD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	0.000206	0.00267	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL12B—ulcerative colitis	0.000206	0.00267	CbGpPWpGaD
Dabigatran etexilate—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000206	0.000887	CcSEcCtD
Dabigatran etexilate—Hypertension—Prednisone—ulcerative colitis	0.000205	0.000883	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000203	0.000873	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000203	0.000873	CcSEcCtD
Dabigatran etexilate—Arthralgia—Prednisone—ulcerative colitis	0.000202	0.00087	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000201	0.000864	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.0002	0.000862	CcSEcCtD
Dabigatran etexilate—F2—GPCR ligand binding—CXCR2—ulcerative colitis	0.000198	0.00256	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000197	0.00255	CbGpPWpGaD
Dabigatran etexilate—Hypersensitivity—Prednisolone—ulcerative colitis	0.000196	0.000846	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Betamethasone—ulcerative colitis	0.000196	0.000843	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Dexamethasone—ulcerative colitis	0.000196	0.000843	CcSEcCtD
Dabigatran etexilate—Urticaria—Triamcinolone—ulcerative colitis	0.000195	0.000839	CcSEcCtD
Dabigatran etexilate—F2—Selenium Micronutrient Network—NFKB1—ulcerative colitis	0.000194	0.00252	CbGpPWpGaD
Dabigatran etexilate—Urticaria—Methylprednisolone—ulcerative colitis	0.000194	0.000837	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Prednisone—ulcerative colitis	0.000194	0.000834	CcSEcCtD
Dabigatran etexilate—ABCB1—Allograft Rejection—CTLA4—ulcerative colitis	0.000194	0.00251	CbGpPWpGaD
Dabigatran etexilate—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000193	0.000833	CcSEcCtD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	0.000193	0.00249	CbGpPWpGaD
Dabigatran etexilate—Infection—Prednisone—ulcerative colitis	0.000192	0.000829	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000192	0.000827	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000192	0.000827	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000192	0.000826	CcSEcCtD
Dabigatran etexilate—Fatigue—Betamethasone—ulcerative colitis	0.000192	0.000826	CcSEcCtD
Dabigatran etexilate—Fatigue—Dexamethasone—ulcerative colitis	0.000192	0.000826	CcSEcCtD
Dabigatran etexilate—Shock—Prednisone—ulcerative colitis	0.000191	0.000821	CcSEcCtD
Dabigatran etexilate—F2—Folate Metabolism—TNF—ulcerative colitis	0.00019	0.00246	CbGpPWpGaD
Dabigatran etexilate—Nervous system disorder—Prednisone—ulcerative colitis	0.00019	0.000818	CcSEcCtD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—IL6—ulcerative colitis	0.000189	0.00244	CbGpPWpGaD
Dabigatran etexilate—Skin disorder—Prednisone—ulcerative colitis	0.000188	0.00081	CcSEcCtD
Dabigatran etexilate—Asthenia—Hydrocortisone—ulcerative colitis	0.000187	0.000805	CcSEcCtD
Dabigatran etexilate—F2—Hemostasis—GNA12—ulcerative colitis	0.000187	0.00242	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CCR6—ulcerative colitis	0.000186	0.00241	CbGpPWpGaD
Dabigatran etexilate—Pruritus—Hydrocortisone—ulcerative colitis	0.000184	0.000793	CcSEcCtD
Dabigatran etexilate—F2—Hemostasis—ITGAL—ulcerative colitis	0.000183	0.00237	CbGpPWpGaD
Dabigatran etexilate—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000182	0.000783	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000182	0.000783	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000181	0.000778	CcSEcCtD
Dabigatran etexilate—UGT1A9—PPARA activates gene expression—PPARG—ulcerative colitis	0.000181	0.00234	CbGpPWpGaD
Dabigatran etexilate—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.00018	0.000776	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000178	0.000767	CcSEcCtD
Dabigatran etexilate—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—ulcerative colitis	0.000177	0.00229	CbGpPWpGaD
Dabigatran etexilate—Urticaria—Dexamethasone—ulcerative colitis	0.000177	0.000761	CcSEcCtD
Dabigatran etexilate—Urticaria—Betamethasone—ulcerative colitis	0.000177	0.000761	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000177	0.00076	CcSEcCtD
Dabigatran etexilate—Dizziness—Prednisolone—ulcerative colitis	0.000176	0.000759	CcSEcCtD
Dabigatran etexilate—Asthenia—Triamcinolone—ulcerative colitis	0.000176	0.000758	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Dexamethasone—ulcerative colitis	0.000176	0.000757	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Betamethasone—ulcerative colitis	0.000176	0.000757	CcSEcCtD
Dabigatran etexilate—Asthenia—Methylprednisolone—ulcerative colitis	0.000176	0.000756	CcSEcCtD
Dabigatran etexilate—CES1—NRF2 pathway—TGFB1—ulcerative colitis	0.000175	0.00227	CbGpPWpGaD
Dabigatran etexilate—Pruritus—Triamcinolone—ulcerative colitis	0.000173	0.000747	CcSEcCtD
Dabigatran etexilate—Pruritus—Methylprednisolone—ulcerative colitis	0.000173	0.000745	CcSEcCtD
Dabigatran etexilate—Dizziness—Hydrocortisone—ulcerative colitis	0.000172	0.000742	CcSEcCtD
Dabigatran etexilate—ABCB1—Allograft Rejection—HLA-DQA1—ulcerative colitis	0.000171	0.00221	CbGpPWpGaD
Dabigatran etexilate—Dyspepsia—Prednisone—ulcerative colitis	0.000171	0.000734	CcSEcCtD
Dabigatran etexilate—Rash—Prednisolone—ulcerative colitis	0.000168	0.000724	CcSEcCtD
Dabigatran etexilate—F2—Metabolism of proteins—MUC2—ulcerative colitis	0.000168	0.00217	CbGpPWpGaD
Dabigatran etexilate—Dermatitis—Prednisolone—ulcerative colitis	0.000168	0.000723	CcSEcCtD
Dabigatran etexilate—F2—Folate Metabolism—TP53—ulcerative colitis	0.000168	0.00217	CbGpPWpGaD
Dabigatran etexilate—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000167	0.000721	CcSEcCtD
Dabigatran etexilate—Fatigue—Prednisone—ulcerative colitis	0.000167	0.000719	CcSEcCtD
Dabigatran etexilate—Headache—Prednisolone—ulcerative colitis	0.000167	0.000719	CcSEcCtD
Dabigatran etexilate—Constipation—Prednisone—ulcerative colitis	0.000166	0.000714	CcSEcCtD
Dabigatran etexilate—Vomiting—Hydrocortisone—ulcerative colitis	0.000166	0.000713	CcSEcCtD
Dabigatran etexilate—Rash—Hydrocortisone—ulcerative colitis	0.000164	0.000707	CcSEcCtD
Dabigatran etexilate—Dermatitis—Hydrocortisone—ulcerative colitis	0.000164	0.000706	CcSEcCtD
Dabigatran etexilate—F2—GPCR ligand binding—PTGER4—ulcerative colitis	0.000164	0.00212	CbGpPWpGaD
Dabigatran etexilate—Headache—Hydrocortisone—ulcerative colitis	0.000163	0.000703	CcSEcCtD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000163	0.00211	CbGpPWpGaD
Dabigatran etexilate—Dizziness—Triamcinolone—ulcerative colitis	0.000162	0.000698	CcSEcCtD
Dabigatran etexilate—Dizziness—Methylprednisolone—ulcerative colitis	0.000162	0.000697	CcSEcCtD
Dabigatran etexilate—Asthenia—Betamethasone—ulcerative colitis	0.00016	0.000687	CcSEcCtD
Dabigatran etexilate—Asthenia—Dexamethasone—ulcerative colitis	0.00016	0.000687	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Prednisone—ulcerative colitis	0.000158	0.000682	CcSEcCtD
Dabigatran etexilate—Nausea—Prednisolone—ulcerative colitis	0.000158	0.000682	CcSEcCtD
Dabigatran etexilate—Pruritus—Betamethasone—ulcerative colitis	0.000157	0.000678	CcSEcCtD
Dabigatran etexilate—Pruritus—Dexamethasone—ulcerative colitis	0.000157	0.000678	CcSEcCtD
Dabigatran etexilate—Vomiting—Triamcinolone—ulcerative colitis	0.000156	0.000671	CcSEcCtD
Dabigatran etexilate—Vomiting—Methylprednisolone—ulcerative colitis	0.000156	0.00067	CcSEcCtD
Dabigatran etexilate—Nausea—Hydrocortisone—ulcerative colitis	0.000155	0.000666	CcSEcCtD
Dabigatran etexilate—Rash—Triamcinolone—ulcerative colitis	0.000155	0.000666	CcSEcCtD
Dabigatran etexilate—Dermatitis—Triamcinolone—ulcerative colitis	0.000154	0.000665	CcSEcCtD
Dabigatran etexilate—Rash—Methylprednisolone—ulcerative colitis	0.000154	0.000664	CcSEcCtD
Dabigatran etexilate—Dermatitis—Methylprednisolone—ulcerative colitis	0.000154	0.000664	CcSEcCtD
Dabigatran etexilate—Urticaria—Prednisone—ulcerative colitis	0.000154	0.000663	CcSEcCtD
Dabigatran etexilate—F2—Folate Metabolism—IL6—ulcerative colitis	0.000154	0.00199	CbGpPWpGaD
Dabigatran etexilate—Headache—Triamcinolone—ulcerative colitis	0.000154	0.000662	CcSEcCtD
Dabigatran etexilate—Headache—Methylprednisolone—ulcerative colitis	0.000153	0.00066	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Prednisone—ulcerative colitis	0.000153	0.00066	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Betamethasone—ulcerative colitis	0.000152	0.000656	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Dexamethasone—ulcerative colitis	0.000152	0.000656	CcSEcCtD
Dabigatran etexilate—F2—Selenium Micronutrient Network—TNF—ulcerative colitis	0.000151	0.00196	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL10—ulcerative colitis	0.000151	0.00195	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—GHRL—ulcerative colitis	0.00015	0.00194	CbGpPWpGaD
Dabigatran etexilate—Dizziness—Dexamethasone—ulcerative colitis	0.000147	0.000634	CcSEcCtD
Dabigatran etexilate—Dizziness—Betamethasone—ulcerative colitis	0.000147	0.000634	CcSEcCtD
Dabigatran etexilate—Nausea—Triamcinolone—ulcerative colitis	0.000146	0.000627	CcSEcCtD
Dabigatran etexilate—Nausea—Methylprednisolone—ulcerative colitis	0.000145	0.000626	CcSEcCtD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000144	0.00186	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000143	0.00185	CbGpPWpGaD
Dabigatran etexilate—Hypersensitivity—Prednisone—ulcerative colitis	0.000143	0.000615	CcSEcCtD
Dabigatran etexilate—Vomiting—Dexamethasone—ulcerative colitis	0.000141	0.000609	CcSEcCtD
Dabigatran etexilate—Vomiting—Betamethasone—ulcerative colitis	0.000141	0.000609	CcSEcCtD
Dabigatran etexilate—Rash—Betamethasone—ulcerative colitis	0.00014	0.000604	CcSEcCtD
Dabigatran etexilate—Rash—Dexamethasone—ulcerative colitis	0.00014	0.000604	CcSEcCtD
Dabigatran etexilate—Dermatitis—Betamethasone—ulcerative colitis	0.00014	0.000604	CcSEcCtD
Dabigatran etexilate—Dermatitis—Dexamethasone—ulcerative colitis	0.00014	0.000604	CcSEcCtD
Dabigatran etexilate—Headache—Betamethasone—ulcerative colitis	0.000139	0.0006	CcSEcCtD
Dabigatran etexilate—Headache—Dexamethasone—ulcerative colitis	0.000139	0.0006	CcSEcCtD
Dabigatran etexilate—Asthenia—Prednisone—ulcerative colitis	0.000139	0.000599	CcSEcCtD
Dabigatran etexilate—Pruritus—Prednisone—ulcerative colitis	0.000137	0.00059	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Prednisone—ulcerative colitis	0.000133	0.000571	CcSEcCtD
Dabigatran etexilate—Nausea—Dexamethasone—ulcerative colitis	0.000132	0.000569	CcSEcCtD
Dabigatran etexilate—Nausea—Betamethasone—ulcerative colitis	0.000132	0.000569	CcSEcCtD
Dabigatran etexilate—UGT2B7—Metabolism—CHP1—ulcerative colitis	0.000131	0.00169	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—CALM3—ulcerative colitis	0.00013	0.00168	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CXCR1—ulcerative colitis	0.00013	0.00168	CbGpPWpGaD
Dabigatran etexilate—Dizziness—Prednisone—ulcerative colitis	0.000128	0.000552	CcSEcCtD
Dabigatran etexilate—F2—GPCR downstream signaling—CCL20—ulcerative colitis	0.000126	0.00162	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—ADRB2—ulcerative colitis	0.000124	0.00161	CbGpPWpGaD
Dabigatran etexilate—Vomiting—Prednisone—ulcerative colitis	0.000123	0.000531	CcSEcCtD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	0.000123	0.00159	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—ALB—ulcerative colitis	0.000123	0.00159	CbGpPWpGaD
Dabigatran etexilate—Rash—Prednisone—ulcerative colitis	0.000122	0.000526	CcSEcCtD
Dabigatran etexilate—F2—Selenium Micronutrient Network—IL6—ulcerative colitis	0.000122	0.00158	CbGpPWpGaD
Dabigatran etexilate—Dermatitis—Prednisone—ulcerative colitis	0.000122	0.000526	CcSEcCtD
Dabigatran etexilate—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—ulcerative colitis	0.000122	0.00158	CbGpPWpGaD
Dabigatran etexilate—Headache—Prednisone—ulcerative colitis	0.000121	0.000523	CcSEcCtD
Dabigatran etexilate—ABCB1—Allograft Rejection—HLA-DRB1—ulcerative colitis	0.000121	0.00157	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PTGS1—ulcerative colitis	0.00012	0.00155	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—GNA12—ulcerative colitis	0.000118	0.00153	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	0.000117	0.00152	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.000117	0.00151	CbGpPWpGaD
Dabigatran etexilate—Nausea—Prednisone—ulcerative colitis	0.000115	0.000496	CcSEcCtD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	0.000114	0.00148	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CCL20—ulcerative colitis	0.000114	0.00147	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—DLD—ulcerative colitis	0.000113	0.00146	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000112	0.00145	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—CALM3—ulcerative colitis	0.000108	0.0014	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—GNA12—ulcerative colitis	0.000107	0.00139	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CHP1—ulcerative colitis	0.000106	0.00137	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—GHRL—ulcerative colitis	0.000106	0.00137	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CCR6—ulcerative colitis	0.000105	0.00136	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CXCR2—ulcerative colitis	0.000102	0.00131	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—NRF2 pathway—TGFB1—ulcerative colitis	0.000101	0.0013	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	9.96e-05	0.00129	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	9.94e-05	0.00129	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CCR6—ulcerative colitis	9.55e-05	0.00124	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—SEL1L—ulcerative colitis	9.31e-05	0.00121	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—PTGER4—ulcerative colitis	9.26e-05	0.0012	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—DLD—ulcerative colitis	9.17e-05	0.00119	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IFNG—ulcerative colitis	8.86e-05	0.00115	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	8.48e-05	0.0011	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	8.48e-05	0.0011	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—GHRL—ulcerative colitis	8.48e-05	0.0011	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—PTGER4—ulcerative colitis	8.41e-05	0.00109	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—ABCB1—ulcerative colitis	8.39e-05	0.00109	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—MMP1—ulcerative colitis	8.34e-05	0.00108	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—CXCL8—ulcerative colitis	8.24e-05	0.00107	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—NRF2 pathway—TGFB1—ulcerative colitis	8.19e-05	0.00106	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL1B—ulcerative colitis	7.9e-05	0.00102	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	7.88e-05	0.00102	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL2—ulcerative colitis	7.87e-05	0.00102	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—ADCY5—ulcerative colitis	7.82e-05	0.00101	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	7.76e-05	0.001	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—GHRL—ulcerative colitis	7.7e-05	0.000996	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CXCR1—ulcerative colitis	7.67e-05	0.000992	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CALM3—ulcerative colitis	7.46e-05	0.000965	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—ADRB2—ulcerative colitis	7.02e-05	0.000908	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCL20—ulcerative colitis	6.73e-05	0.000871	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—MMP1—ulcerative colitis	6.56e-05	0.000849	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—ADRB2—ulcerative colitis	6.37e-05	0.000825	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GNA12—ulcerative colitis	6.33e-05	0.000819	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—ALB—ulcerative colitis	6.32e-05	0.000818	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	6.14e-05	0.000795	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CXCR2—ulcerative colitis	6e-05	0.000777	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CXCL8—ulcerative colitis	6e-05	0.000776	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	5.97e-05	0.000773	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—ADCY5—ulcerative colitis	5.96e-05	0.000771	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—JAK2—ulcerative colitis	5.88e-05	0.00076	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PPARG—ulcerative colitis	5.84e-05	0.000755	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—TNF—ulcerative colitis	5.73e-05	0.000742	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCR6—ulcerative colitis	5.64e-05	0.00073	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PTGS1—ulcerative colitis	5.46e-05	0.000706	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—ADCY5—ulcerative colitis	5.41e-05	0.0007	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MAML2—ulcerative colitis	5.35e-05	0.000692	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	5.28e-05	0.000684	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—ALB—ulcerative colitis	5.25e-05	0.000679	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—IL2—ulcerative colitis	5.13e-05	0.000663	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PTGER4—ulcerative colitis	4.97e-05	0.000643	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CALM3—ulcerative colitis	4.91e-05	0.000636	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CHP1—ulcerative colitis	4.87e-05	0.000631	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	4.85e-05	0.000628	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PTGS2—ulcerative colitis	4.59e-05	0.000594	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GHRL—ulcerative colitis	4.55e-05	0.000589	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PTGS1—ulcerative colitis	4.43e-05	0.000574	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CALM3—ulcerative colitis	4.4e-05	0.00057	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	4.36e-05	0.000564	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—RIPK2—ulcerative colitis	4.34e-05	0.000561	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—CXCL8—ulcerative colitis	4.22e-05	0.000546	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—DLD—ulcerative colitis	4.21e-05	0.000544	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	4.19e-05	0.000542	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—TGFB1—ulcerative colitis	4e-05	0.000517	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CALM3—ulcerative colitis	3.99e-05	0.000517	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ABCB1—ulcerative colitis	3.82e-05	0.000494	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	3.82e-05	0.000494	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ADRB2—ulcerative colitis	3.76e-05	0.000487	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—JAK2—ulcerative colitis	3.71e-05	0.000481	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	3.64e-05	0.000471	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ADCY5—ulcerative colitis	3.56e-05	0.000461	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CXCL8—ulcerative colitis	3.39e-05	0.000439	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—JAK2—ulcerative colitis	3.37e-05	0.000436	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—TP53—ulcerative colitis	3.29e-05	0.000426	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—IL2—ulcerative colitis	3.24e-05	0.000419	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ADCY5—ulcerative colitis	3.2e-05	0.000413	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ABCB1—ulcerative colitis	3.1e-05	0.000402	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CXCL8—ulcerative colitis	3.08e-05	0.000398	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	3.03e-05	0.000392	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—IL2—ulcerative colitis	2.94e-05	0.000381	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ADCY5—ulcerative colitis	2.9e-05	0.000375	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	2.84e-05	0.000367	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	2.83e-05	0.000366	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PPARG—ulcerative colitis	2.66e-05	0.000344	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	2.49e-05	0.000323	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ALB—ulcerative colitis	2.39e-05	0.000309	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PPARG—ulcerative colitis	2.16e-05	0.000279	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PTGS2—ulcerative colitis	2.09e-05	0.000271	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PTGS1—ulcerative colitis	2.03e-05	0.000263	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—JAK2—ulcerative colitis	1.99e-05	0.000258	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ALB—ulcerative colitis	1.94e-05	0.000251	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—RELA—ulcerative colitis	1.93e-05	0.00025	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.9e-05	0.000246	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CALM3—ulcerative colitis	1.83e-05	0.000237	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CXCL8—ulcerative colitis	1.82e-05	0.000235	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IL2—ulcerative colitis	1.74e-05	0.000225	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—IL6—ulcerative colitis	1.73e-05	0.000224	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PTGS2—ulcerative colitis	1.7e-05	0.00022	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MMP9—ulcerative colitis	1.64e-05	0.000213	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NFKB1—ulcerative colitis	1.63e-05	0.000211	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—STAT3—ulcerative colitis	1.46e-05	0.000189	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TGFB1—ulcerative colitis	1.36e-05	0.000175	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ADCY5—ulcerative colitis	1.33e-05	0.000172	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TP53—ulcerative colitis	1.12e-05	0.000144	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IL6—ulcerative colitis	1.02e-05	0.000132	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PPARG—ulcerative colitis	9.91e-06	0.000128	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ALB—ulcerative colitis	8.91e-06	0.000115	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PTGS2—ulcerative colitis	7.79e-06	0.000101	CbGpPWpGaD
